Head and Neck Neoplasms: all 2,403 studies

Page 9 of 25. Open to participants first (559), then studies with results posted, then the rest; newest registration first within each.

• Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck CancerCompletedNCT00851877Phase 1/2Results posted
• Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck CancerCompletedNCT00851253Not applicableResults posted
• Pilot Study of AuroLase(tm) Therapy in Refractory and/or Recurrent Tumors of the Head and NeckCompletedNCT00848042Not applicableResults posted
• A Multi - Center Study Of PET Imaging With [F-18] FLT & [F-18] FDG in Cancer Patients for Treatment EvaluationCompletedNCT00847509Not applicableResults posted
• Tadalafil in Treating Patients Undergoing Surgery for Cancer of the Oral Cavity or OropharynxCompletedNCT00843635Not applicableResults posted
• Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck CancerCompletedNCT00833261Phase 2Results posted
• Using Traditional Acupuncture in the Management of Cancer Treatment Related LymphoedemaCompletedNCT00828516Not applicableResults posted
• Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck CancerCompletedNCT00820248Phase 3Results posted
• Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck CancerCompletedNCT00798655Phase 2Results posted
• Open-Label Trial Of Oral PF-00299804 By Continuous Dosing In Patients With Recurrent Or Metastatic Head And Neck Squamous Cell CancerCompletedNCT00768664Phase 2Results posted
• Maintenance of Tarceva (Erlotinib) in Patients With Locally Advanced Head and Neck CancerTerminatedNCT00750555Phase 2Results posted
• Phase II Study of TAS-106 to Treat Head and Neck CancerTerminatedNCT00737360Phase 2Results posted
• Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and NeckCompletedNCT00725764Phase 2Results posted
• F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer PatientsCompletedNCT00721799Phase 2Results posted
• Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerCompletedNCT00721513Phase 2Results posted
• Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and NeckCompletedNCT00720304Phase 2Results posted
• Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck CancerTerminatedNCT00720083Phase 2Results posted
• Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck CancerCompletedNCT00713219Phase 2Results posted
• Zalutumumab in Combination With Radiotherapy in Head and Neck Cancer Patients Ineligible for Platinum Based ChemotherapyTerminatedNCT00707655Phase 1/2Results posted
• Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck CancerCompletedNCT00703976Phase 2Results posted
• Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic NeoplasmsCompletedNCT00666926Phase 1Results posted
• Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx CancerCompletedNCT00665392Phase 2Results posted
• Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck CancerCompletedNCT00656513Phase 2/3Results posted
• Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00639769Phase 2Results posted
• Efficacy of Electrical Stimulation for Dysphagia in Head & Neck Cancer PatientsCompletedNCT00629265Not applicableResults posted
• A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent ChemotherapyCompletedNCT00626639Phase 1/2Results posted
• Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00608205Phase 3Results posted
• Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer PatientsCompletedNCT00606294Not applicableResults posted
• Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck CancerTerminatedNCT00591149Phase 2Results posted
• A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC)CompletedNCT00589667Phase 2Results posted
• Optimized Intensity Modulated Irradiation for Head and Neck CancerCompletedNCT00580983Not applicableResults posted
• Real-Time Internet Evaluation of SwallowingCompletedNCT00580138Results posted
• Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck CancerTerminatedNCT00573989Phase 1/2Results posted
• Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and NeckTerminatedNCT00570674Phase 1/2Results posted
• UAB 0718 - Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck CancerCompletedNCT00570232Phase 2Results posted
• Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell CancerTerminatedNCT00566540Phase 2Results posted
• A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and AngiogenesisCompletedNCT00565721Phase 2Results posted
• Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT00547157Phase 2Results posted
• Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck CancerCompletedNCT00544414Phase 2Results posted
• Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving TreatmentCompletedNCT00536172Phase 4Results posted
• Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Recurrent Mouth or Throat Dysplasia or Recurrent In Situ Cancer or Stage I Cancer of the Mouth or ThroatTerminatedNCT00530088Not applicableResults posted
• Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung CancerTerminatedNCT00527982Phase 2Results posted
• Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and NeckCompletedNCT00519077Phase 2Results posted
• BIBW 2992 (Afatinib) in Head & Neck CancerCompletedNCT00514943Phase 2Results posted
• Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00513435Phase 2Results posted
• Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck CancerCompletedNCT00509665Phase 2Results posted
• Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00507767Phase 2Results posted
• Dynasplint Therapy for Trismus in Head and Neck CancerCompletedNCT00507208Not applicableResults posted
• Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck CancerCompletedNCT00503997Phase 2Results posted
• Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck CancerCompletedNCT00500760Phase 2Results posted
• A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck CancerCompletedNCT00490282Not applicableResults posted
• Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent ChemotherapyTerminatedNCT00490061Phase 2Results posted
• Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell CancerCompletedNCT00485485Phase 2Results posted
• Robotic Assisted Surgery in Upper Aerodigestive Tract SurgeryCompletedNCT00473564Not applicableResults posted
• Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck CancerCompletedNCT00468169Phase 2Results posted
• Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck CancerCompletedNCT00462735Phase 2Results posted
• Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck CancerCompletedNCT00460265Phase 3Results posted
• PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of ResponseCompletedNCT00454779Phase 2Results posted
• Erlotinib (Tarceva) During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck CancerTerminatedNCT00448240Phase 2/3Results posted
• PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)CompletedNCT00446446Phase 2Results posted
• Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00425750Phase 2Results posted
• Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After SurgeryCompletedNCT00424255Phase 3Results posted
• Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00423930Phase 2Results posted
• Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED)TerminatedNCT00423150Phase 2Results posted
• A Study for Patients With Head and Neck CancerCompletedNCT00415194Phase 3Results posted
• A Study of Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell CancerTerminatedNCT00412217Phase 3Results posted
• A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00409565Phase 2Results posted
• Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer TreatmentTerminatedNCT00409331Phase 2Results posted
• Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck CancerTerminatedNCT00401401Phase 1/2Results posted
• Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck CancerTerminatedNCT00394147Phase 2Results posted
• Treatment of Head & Neck Cancer With Chemotherapy and RadiationCompletedNCT00392704Phase 2Results posted
• Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck CancerCompletedNCT00387335Phase 2Results posted
• Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck CancerCompletedNCT00387127Phase 2Results posted
• Zalutumumab in Patients With Non-curable Head and Neck CancerCompletedNCT00382031Phase 3Results posted
• Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck CancerTerminatedNCT00360971Phase 3Results posted
• Use of Cone Beam Kilovoltage Imaging in Patients Receiving Radiation Therapy for Head and Neck CancerTerminatedNCT00358007Phase 2Results posted
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerTerminatedNCT00352118Phase 2Results posted
• Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck CancerCompletedNCT00352105Phase 1/2Results posted
• Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck (GCC 0442)CompletedNCT00343083Phase 2Results posted
• S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck CancerCompletedNCT00337129Phase 2Results posted
• Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With CetuximabTerminatedNCT00319839Phase 2Results posted
• Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA)CompletedNCT00304278Phase 2Results posted
• Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck CancerCompletedNCT00301028Phase 2Results posted
• Pemetrexed Chemotherapy in Poor-Risk Patients With Advanced Head and Neck CancerCompletedNCT00293579Phase 2Results posted
• GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck CancerCompletedNCT00293462Phase 3Results posted
• Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00281840Phase 2Results posted
• EVALUATION OF AMIFOSTINE FOR MUCOSAL AND HEMOPOETIC PROTECTION AND CARBOPLATIN, TAXOL, RADIOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH HEAD AND NECK CANCER.(GCC 0202)CompletedNCT00270790Phase 2Results posted
• Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck MalignanciesCompletedNCT00266279Phase 2Results posted
• Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00265941Phase 3Results posted
• Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck CancerTerminatedNCT00256308Phase 2Results posted
• Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck CancerTerminatedNCT00256295Phase 2Results posted
• Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck CancerCompletedNCT00248560Phase 2Results posted
• The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck CancerCompletedNCT00243347Phase 1Results posted
• Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck CancerCompletedNCT00226239Phase 2Results posted
• Study of Pemetrexed and Bevacizumab in Patients With Head and Neck CancerCompletedNCT00222729Phase 2Results posted
• Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck CancerCompletedNCT00176254Phase 2Results posted
• A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck CancerCompletedNCT00148122Phase 2Results posted
• Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck CancerCompletedNCT00140556Early Phase 1Results posted
• Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME)CompletedNCT00122460Phase 3Results posted
• Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)CompletedNCT00117572Phase 3Results posted

← Head and Neck Neoplasms overview